Share story
AI

Anthropic says it cannot manipulate Claude once military deploys it

Anthropic says it cannot manipulate Claude once military deploys it Image: Primary
Anthropic filed a legal response stating it cannot remotely manipulate Claude once deployed by the military, WIRED reported. Once in an air-gapped environment, the company has no ability to alter behavior or disable functionality. The model runs as static software on military infrastructure. The filing addresses concerns in the ongoing dispute with the Trump administration, which blacklisted Anthropic from federal contracts.
Sources
WIRED
In this story
Anthropic US Government
Published by Tech & Business, a media brand covering technology and business. This story was sourced from WIRED and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Capital
AI Capital

Numica raises $21M to acquire small US accounting practices

Numica has raised $21M in equity and debt from Roosh X and Flashpoint Capital to acquire more small US accounting firms, The Next Web reports. The New York startup targets practices with annual revenue of $700,000 to $5m, often owned by accountants approaching retirement.

The Next Web
Capital AI
Capital AI

Kabilio raises €10M to develop AI agents for accounting firms

Barcelona startup Kabilio has raised €10M in a round led by Picus Capital and Visionaries, with participation from Spain's technology and innovation agency CDTI. The financing brings its total funding to €14m and will fund an AI agent for accounting firms.

The Next Web
Capital AI
Capital AI

Mindmax raises $3.3m for conversational AI exam tutor

London startup Mindmax announced $3.3m (£2.5m) in pre-seed funding to build an AI tutor for professional exams and workplace skills. Concept Ventures led the round, joined by Redrice Ventures, Daybreak Ventures and Lerer Hippeau.

The Next Web
AI Capital
AI Capital

Isomorphic Labs seeks roughly $5 billion in funding talks

Alphabet's Isomorphic Labs is in talks to raise roughly $5 billion to support its use of artificial intelligence for drug discovery, Bloomberg reported, citing people familiar with the matter. The financing remains under discussion rather than a completed fundraising.

Bloomberg Technology